XJSE
DCP
Market cap1.25bUSD
Oct 30, Last price
2,442.00ZAR
1D
-12.63%
1Q
-18.68%
Jan 2017
9.02%
IPO
16.84%
Name
Dis-Chem Pharmacies Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dis-Chem Pharmacies Limited (DCP.JO) is a leading South African enterprise engaged in both the retail and wholesale supply of healthcare products and pharmaceuticals. The company operates through two distinct segments: Retail and Wholesale. Its extensive retail network encompasses numerous stores that provide a wide array of offerings, including dispensary services, personal care and beauty products, health and nutrition items, and baby essentials. These outlets further enhance their customer experience by offering ancillary services like healthcare clinics and hair and beauty salons. Dis-Chem also maintains an online platform that facilitates convenient click & collect services for its customers. On the wholesale front, the company handles the distribution of pharmaceutical, health, and general front-shop products, delivers specialized pharma-logistic solutions, and manages customer loyalty initiatives. Established in 1978 and headquartered in Midrand, South Africa, Dis-Chem boasts a substantial presence with 289 stores spread across all nine South African provinces, supplemented by four outlets in Namibia and two in Botswana.
Key people
Independent Non-Executive Chairman of the Board · since 2016
Julia Pope
Chief Financial Officer, Executive Director · since 2023
Stanley Goetsch
Executive Director · since 2022
Rui Morais
Group Chief Executive Officer, Executive Director · since 2023
Ivan Saltzman
Co-Founder, Executive Director · since 2023
Saul Saltzman
Executive Director · since 2016
Q. Cranje
Executive Officer · since 2023
Z Dinda
Executive Officer · since 2023
R. Govender
Executive Officer · since 2023
Katlego Kobue
Non-Independent Non-Executive Director · since 2021
Anuschka Coovadia
Independent Non-Executive Director · since 2016
Happy Masondo
Independent Non-Executive Director · since 2022
Johannes Mthimunye
Independent Non-Executive Director · since 2016
Alupheli Sithebe
Independent Non-Executive Director · since 2021
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑02 | 2025‑02 | 2024‑02 | 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||